The famous physicist Stephen Hawking recognised that “our future is a race between the growing power of our technology and the wisdom with which we use it”. The remarkable advances in the fields of artificial intelligence (AI) and machine learning (ML) over the past few years have attracted considerable attention – and fuelled fears. This year’s SCTO Symposium takes a closer look at this topic from various perspectives.
We have worked closely with Ente Ospedaliero Cantonale (EOC) in Lugano to put together a programme that is rich in variety. Along with other leading experts, we have invited Professor Michael Bronstein to speak at the symposium. Bronstein is a DeepMind Professor of Artificial Intelligence at the University of Oxford in the UK and a global leader in the field of geometric machine learning, a field that has recently found a wide range of applications from recommender systems to drug development.
We will use presenters’ contributions and practical national and international examples to take a closer look at the following questions:
- To what extent is the use of AI and ML in clinical research already a reality?
- How can the use of AI and ML benefit clinical research? What kind of clinical research is needed to validate its use?
- What are the opportunities, challenges, and risks of these new approaches?
- With every new technology, the question of regulation inevitably arises. How much regulation is needed, and what (new) ethical questions need to be answered?
- How do key Swiss stakeholders in clinical research currently address these new technological advances and how are they preparing for the future?
The symposium will be held in English.
The programme of the SCTO Symposium 2022 with more information is available below.